Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8

general

Stage IIA includes: T1-2, N1,2, M0, B0,1. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. T2: Patches, papules, or plaques covering 10% or more of the skin surface. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% o

10

Centers

1

Active Trials

—

Cancer Funding

Top Centers for Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8(10)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Winship Cancer InstituteAtlanta, GA
NCI Comprehensive
High-Volume Research Center
75.2
2
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
52.8
3
Stanford Cancer InstitutePalo Alto, CA
NCI Comprehensive
52.8
4
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
52.8
5
University of Wisconsin Carbone Cancer CenterMadison, WI
NCI Comprehensive
52.8
6
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
52.8
7
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
52.8
8
University of Illinois Cancer CenterChicago, IL
52.8
9
Cancer Center at IllinoisUrbana, IL
52.8
10
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
52.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →